SIAH1 and cancer: This idea is supported by several previous studies that demonstrated that the RING domain-deleted SIAH1 or SIAH2 mutants (termed SIAH1/2 dominant-negative) functionally ablated endogenous activity of SIAH1 and SIAH2 in cancer biology [23, 27, 32, 38, 42, 43].